Pharmacies Don't Need Pharmacists Anymore — And That Should Worry Everyone
When Queue emerged from stealth this week with $12.6 million to build fully autonomous pharmacies, the company promised something remarkable: prescription filling and verification at 96% lower cost than traditional pharmacies, with no on-site pharmacists required. It's an impressive technical achievement. It's also a preview of something unsettling that's accelerating across the AI and robotics landscape.
We're not talking about automating repetitive warehouse tasks or replacing assembly line workers anymore. We're watching AI systems target professions that require years of specialized education, state licensing, and are governed by strict regulatory frameworks designed to protect public safety. Pharmacists spend six to eight years in education and training. They're healthcare professionals who counsel patients, catch dangerous drug interactions, and serve as accessible medical advisors in communities. Queue's system promises to do all of this without a human in the loop.
The timing is particularly notable. Just this week, the UN's Independent International Scientific Panel on Artificial Intelligence released a report warning that policymakers are struggling to keep pace with AI development, with capabilities doubling every few months. That's not hyperbole — it's the regulatory reality. Queue's autonomous pharmacy will likely launch before most states have even begun to consider what licensing requirements should look like for AI-powered pharmaceutical systems.
This pattern is repeating across industries. Anthropic just released Claude Sonnet 5 specifically optimized for "agentic AI tasks" — autonomous systems that can complete complex workflows without human oversight. Google launched Gemini Spark to automate professional knowledge work like document management and spreadsheet creation. These aren't tools that augment human capabilities; they're systems designed to operate independently.
The cost savings are undeniable, and Queue's promise to address critical pharmacy deserts in underserved communities is genuinely compelling. But we should be honest about what's being traded away. When a community pharmacy closes and is replaced by an autonomous system, that community loses more than prescription access — it loses a healthcare professional who knows their patients, understands their concerns, and can provide the kind of contextual medical guidance that no AI system currently replicates convincingly.
What makes Queue's announcement particularly significant is that it's happening in a highly regulated space where patient safety is paramount. If autonomous systems can gain acceptance in pharmacy — an industry where errors can be fatal — then virtually no licensed profession is off the table. Radiology. Legal research. Tax preparation. Psychological counseling. The technical barriers are falling faster than the ethical frameworks are being built.
The real question isn't whether these systems can technically perform the tasks. Queue has apparently demonstrated that they can. The question is whether we're comfortable with the speed at which entire professions are being automated away, and whether the cost savings justify the loss of human expertise, judgment, and community relationships that take years to develop.
Right now, that conversation is barely happening. The UN report got it right: policymakers are struggling to keep up. By the time they do, the autonomous pharmacy may already be as common as the self-checkout lane.